fbpx
November 16, 2020

VNS May Improve Upper-Limb Rehabilitation After Stroke VNS May Improve Upper-Limb Rehabilitation After Stroke

Vagus nerve stimulation (VNS) plus rehabilitation provided greater functional improvements compared with sham stimulation plus rehabilitation for patients with moderate to severe arm impairment after ischemic […]
November 16, 2020

Health Officials Need Contact With Biden’s Team, Fauci Says Health Officials Need Contact With Biden’s Team, Fauci Says

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Government health officials need to begin working with President-elect Joe Biden’s transition […]
November 16, 2020

In Those With Obesity, Will Losing Weight Cut COVID-19 Severity? In Those With Obesity, Will Losing Weight Cut COVID-19 Severity?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. As study after study piles up showing that those with obesity who […]
November 16, 2020

OMEMI: No Secondary Prevention Benefit With Omega-3s in Elderly OMEMI: No Secondary Prevention Benefit With Omega-3s in Elderly

Omega-3 fatty acids on top of standard care did not reduce major cardiovascular events or death in elderly survivors of an acute myocardial infarction (MI) in […]
November 15, 2020

SAMSON Pins Most Muscle Pain With Statins on the Nocebo Effect SAMSON Pins Most Muscle Pain With Statins on the Nocebo Effect

A novel randomized trial taking on a vexing issue around one of the world’s most commonly prescribed medications has concluded that frequently intolerable statin side effects, […]
November 15, 2020

STRENGTH Trial Questions CV Benefit of High-Dose Omega-3s STRENGTH Trial Questions CV Benefit of High-Dose Omega-3s

Questions about the cardiovascular benefit of omega-3 fatty acids and the high-dose eicosapentaenoic acid (EPA) product, icosapent ethyl (Vascepa, Amarin), have resurfaced with the presentation and […]
November 15, 2020

Mixed Outcomes in Tenofovir Trial for Chronic Hepatitis B Mixed Outcomes in Tenofovir Trial for Chronic Hepatitis B

About one-third of patients with chronic hepatitis B maintained a profile consistent with inactive disease 1 year after withdrawal from treatment in the randomized HBRN trial, which compared […]
November 15, 2020

FDA-Approved Peanut Immunotherapy Protocol Comes With a Cost FDA-Approved Peanut Immunotherapy Protocol Comes With a Cost

Peanut allergy immunotherapy now comes with approval from the US Food and Drug Administration (FDA), but it also comes with protocols, standards, and paperwork. Whether it […]
November 15, 2020

Empagliflozin Favorably Reshaped LVs in HFrEF Patients Empagliflozin Favorably Reshaped LVs in HFrEF Patients

Treatment with the SGLT2 inhibitor empagliflozin led to significant reductions in both left ventricular end systolic and diastolic volumes in two independent randomized studies of patients […]
Prev page
12345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182838485868788899091929394959697989910010110210310410510610710810911011111211311411511611711811912012112212312412512612712812913013113213313413513613713813914014114214314414514614714814915015115215315415515615715815916016116216316416516616716816917017117217317417517617717817918018118218318418518618718818919019119219319419519619719819920020120220320420520620720820921021121221321421521621721821922022122222322422522622722822923023123223323423523623723823924024124224324424524624724824925025125225325425525625725825926026126226326426526626726826927027127227327427527627727827928028128228328428528628728828929029129229329429529629729829930030130230330430530630730830931031131231331431531631731831932032132232332432532632732832933033133233333433533633733833934034134234334434534634734834935035135235335435535635735835936036136236336436536636736836937037137237337437537637737837938038138238338438538638738838939039139239339439539639739839940040140240340440540640740840941041141241341441541641741841942042142242342442542642742842943043143243343443543643743843944044144244344444544644744844945045145245345445545645745845946046146246346446546646746846947047147247347447547647747847948048148248348448548648748848949049149249349449549649749849950050150250350450550650750850951051151251351451551651751851952052152252352452552652752852953053153253353453553653753853954054154254354454554654754854955055155255355455555655755855956056156256356456556656756856957057157257357457557657757857958058158258358458558658758858959059159259359459559659759859960060160260360460560660760860961061161261361461561661761861962062162262362462562662762862963063163263363463563663763863964064164264364464564664764864965065165265365465565665765865966066166266366466566666766866967067167267367467567667767867968068168268368468568668768868969069169269369469569669769869970070170270370470570670770870971071171271371471571671771871972072172272372472572672772872973073173273373473573673773873974074174274374474574674774874975075175275375475575675775875976076176276376476576676776876977077177277377477577677777877978078178278378478578678778878979079179279379479579679779879980080180280380480580680780880981081181281381481581681781881982082182282382482582682782882983083183283383483583683783883984084184284384484584684784884985085185285385485585685785885986086186286386486586686786886987087187287387487587687787887988088188288388488588688788888989089189289389489589689789889990090190290390490590690790890991091191291391491591691791891992092192292392492592692792892993093193293393493593693793893994094194294394494594694794894995095195295395495595695795895996096196296396496596696796896997097197297397497597697797897998098198298398498598698798898999099199299399499599699799899910001001100210031004100510061007100810091010101110121013101410151016101710181019102010211022102310241025102610271028102910301031103210331034103510361037103810391040104110421043104410451046104710481049105010511052105310541055105610571058105910601061
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0